부산대학교 도서관

In Urologic Oncology: Seminars and Original Investigations 2008 26(6):691-691

Bosland, Maarten C., DVSc, Ph.D.

Urologic Oncology: Seminars and Original Investigations. 22(5):436-437

Urologic Oncology: Seminars and Original Investigations. 22:436-437

Alchoueiry M; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Mansour H; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Khabibullin D; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Han T; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Chaturantabut S; Broad Institute of MIT and Harvard; Cambridge, MA.; Bzeih W; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Tang Y; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Williams JF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Priolo C; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Sellers WR; Broad Institute of MIT and Harvard; Cambridge, MA.; Henske EP; Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: ehenske@bwh.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

van Tienen LM; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: thesellerslab@broadinstitute.org.; Bayoumi S; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.; Muneeruddin K; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Leymarie N; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Popa A; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Shekhar M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Mueller M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Li R; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.; Zak KM; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Chilukuri H; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kornfilt DJP; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Atack TC; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kesar D; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bian Y; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Shaw KL; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Jandova Z; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Trollmann P; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Geist L; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Stolt-Bergner P; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Rumpel K; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Kessler D; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Sellers WR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: wsellers@broadinstitute.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

Ellis H; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Mass General Brigham Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Balasooriya ER; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Varkaris A; Mass General Brigham Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA.; Hajian B; Center for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, USA.; Wan J; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Shekhar M; Center for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, USA.; Gritti I; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Vijay V; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Albertelli L; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Piot S; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Lau K; Mass General Brigham Cancer Institute, Boston, USA.; Kehlmann A; Mass General Brigham Cancer Institute, Boston, USA.; Chevalier N; Mass General Brigham Cancer Institute, Boston, USA.; Nugent FW; Tufts Medical Center, Boston, USA.; Zhen Y; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Silveira VS; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA.; Sellers WR; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA; Dana-Farber Cancer Institute, Boston, USA.; Corcoran RB; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Mass General Brigham Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA.; Juric D; Mass General Brigham Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA. Electronic address: juric.dejan@mgh.harvard.edu.; Bardeesy N; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA. Electronic address: bardeesy.nabeel@mgh.harvard.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Baars B; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Orive-Ramos A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Emmett MJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Gaire B; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Desaunay M; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Kou Z; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Li G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Adamopoulos C; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Aaronson SA; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Wang S; Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Pharmacology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Medicinal Chemistry, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Sellers WR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Martin T; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Gavathiotis E; Department of Biochemistry, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, New York, New York.; Department of Medicine, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, New York, New York.; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, New York, New York.; Poulikakos PI; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Greulich H; Chen TH; Feng W; Jänne PA; Alvarez JV; Zappaterra M; Bulmer SE; Frank DA; Hahn WC; Sellers WR; Meyerson M

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE; PubMed not MEDLINE

Knoll N; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia.; University of Heidelberg, Heidelberg, Germany.; Masser S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz and BioTechMed-Graz, Graz, Austria.; Bordas B; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Ebright RY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Li G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kesar D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Destefanis E; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Kania N; Dana-Farber Cancer Institute, Boston, Massachusetts.; Rodriguez DJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Jen J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Zagar SE; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Mensah C; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Chen Z; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Moffitt SJ; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Enakireru EM; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Erasmus Mundus Joint Masters. University of Calabria, Calabria, Italy.; He Y; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Feng B; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Chokshi MK; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Jin CY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Raghavan S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Sellers WR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Mulvaney KM; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia.; Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Vijay V; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Karisani N; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Shi L; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Hung YH; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Vu P; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Kattel P; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Kenney L; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Merritt J; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Adil R; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Wu Q; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Zhen Y; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Morris R; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Kreuzer J; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Kathiresan M; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Herrera Lopez XI; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Ellis H; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Gritti I; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Lecorgne L; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Farag I; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Popa A; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Shen W; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Kato H; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Xu Q; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Balasooriya ER; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Wu MJ; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Wan J; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kondo H; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Chaturantabut S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Raghavan S; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.; Patnaik S; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.; Shen M; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.; Kelley RK; Division of Hematology-Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Cleary JM; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.; Lawrence MS; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Root DE; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Patra KC; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Department of Cancer Biology, University of Cincinnati, Cincinnati, Ohio.; Silveira VS; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Benes CH; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Deshpande V; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts.; Juric D; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Sellers WR; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ferrone CR; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Haas W; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Vazquez F; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Getz G; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts.; Bardeesy N; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Shirole NH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Kesar D; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Lee Y; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Goodale A; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Syamala S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Kukreja S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Li R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Yu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Goldman S; Nascent Transcriptomics Core, Harvard Medical School, Boston, Massachusetts.; Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Adelman K; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.; Doench JG; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Sellers WR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Howard Hughes Medical Institute, Chevy Chase, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Shaw K; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Stegmaier K; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Varmus H; Meyer Cancer Center, Weill-Cornell Medicine, New York, NY, USA.; Sellers WR; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: wsellers@broadinstitute.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE

Tiedt, R; King, FJ; Stamm, C; Niederst, MJ; Delach, S; Zumstein-Mecker, S; Meltzer, J; Mulford, IJ; Labrot, E; Engstler, BS; Baltschukat, S; Kerr, G; Golji, J; Wyss, D; Schnell, C; Ainscow, E; Engelman, JA; Sellers, WR; Barretina, J; Caponigro, G; Porta, DG

Cell Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Chaturantabut S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.; Oliver S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Frederick DT; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Kim JJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Robinson FP; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Sinopoli A; Ridgeline Discovery GmbH, Basel, Switzerland.; Song TY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; He Y; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Chang YC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Rodriguez DJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Chang L; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Kesar D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Ching M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dzvurumi R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Atari A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Tseng YY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Bardeesy N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Sellers WR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

Jin CY; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Hunkeler M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Mulvaney KM; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Sellers WR; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: eric_fischer@dfci.harvard.edu.

Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

Fan AT; Department of Chemistry and Biochemistry, University of California, San Diego.; Gadbois GE; Department of Chemistry and Biochemistry, University of California, San Diego.; Huang HT; The Broad Institute of Harvard and MIT.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Chaudhry C; Discovery Technologies Molecular Pharmacology, J&J Innovative Medicine, Spring House, Pennsylvania, 19477, United States.; Jiang J; Department of Chemistry and Biochemistry, University of California, San Diego.; Sigua LH; Medical Scientist Training Program, University of California, San Diego.; Smith ER; Department of Chemistry and Biochemistry, University of California, San Diego.; Wu S; Department of Chemistry and Biochemistry, University of California, San Diego.; Poirier GJ; Department of Chemistry and Biochemistry, University of California, San Diego.; Dunne-Dombrink K; Department of Chemistry and Biochemistry, University of California, San Diego.; Goyal P; Department of Chemistry and Biochemistry, University of California, San Diego.; Tao AJ; Department of Chemistry and Biochemistry, University of California, San Diego.; Sellers WR; The Broad Institute of Harvard and MIT.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston.; Ferguson FM; Department of Chemistry and Biochemistry, University of California, San Diego.; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego.

Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773 (Electronic) Linking ISSN: 14337851 NLM ISO Abbreviation: Angew Chem Int Ed Engl Subsets: MEDLINE

BENTIRES ALJ M; PAEZ JG; DAVID FS; KEILHACK H; HALMOS B; NAOKI K; MARIS JM; RICHARDSON A; BARDELLI, Alberto; SUGARBAKER DJ; RICHARDS WG; DU J; GIRARD L; MINNA JD; LOH ML; FISHER DE; VELCULESCU VE; VOGELSTEIN B; MEYERSON M; SELLERS WR; NEEL B.G.

Cancer Research. 64:8816-8820

Bondeson DP; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Mullin-Bernstein Z; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Oliver S; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Skipper TA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Atack TC; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bick N; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ching M; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Guirguis AA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Kwon J; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Langan C; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Millson D; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Paolella BR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Tran K; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Wie SJ; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Vazquez F; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Tothova Z; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Golub TR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Sellers WR; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ianari A; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. aleianari12@gmail.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Chaturantabut S; Oliver S; Frederick DT; Kim J; Robinson FP; Sinopoli A; Song TY; Rodriguez DJ; Chang L; Kesar D; He Y; Ching M; Dzvurumi R; Atari A; Tseng YY; Bardeesy N; Sellers WR

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Huang HT; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Lumpkin RJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Tsai RW; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Su S; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Zhao X; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Xiong Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Chen J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Mageed N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Sellers WR; Broad Institute of Harvard and MIT, Cambridge, MA, USA. wsellers@broadinstitute.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wsellers@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. wsellers@broadinstitute.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE